Organization
Tata Memorial Hospital
7 clinical trials
6 abstracts
Abstract
Phase 3 randomized study for evaluation of physician choice Rx and triple metronomic as second-line therapy in head and neck cancer (CRSF 2021-HN-001).Org: Narayana Multispeciality Hospital, Tata Memorial Hospital, Homi Bhabha cancer hospital and research centre, Regency Hospital, National Cancer Insitute,
Abstract
Retrospective analysis: Does 5-FU dose adjustment per DPYD mutation status affect toxicity?Org: SUNY Upstate Medical University, Tata Memorial Centre, Hinduja Hospital, Tata Memorial Hospital,
Abstract
SHADOW study: Comparison of conventional clinical follow-up with clinician led video follow-up in newly diagnosed patients with intermediate and high grade glioma receiving adjuvant temozolomide therapy.Org: Tata Memorial Centre, Tata Memorial Hospital, Actrec Tata Memorial Centre,
Clinical trial
A Randomized Controlled Trial of Neoadjuvant Weekly Paclitaxel Versus Weekly Paclitaxel Plus Weekly Carboplatin In Women With Large Operable or Locally Advanced, Triple Negative Breast CancerStatus: Active (not recruiting), Estimated PCD: 2025-11-30
Abstract
The efficacy of primary progesterone on survival in early breast cancer: A real world scenario.Org: Tata Memorial Hospital, Homi Bhabha National Institute,
Abstract
MET exon 14 skipping in NSCLC: An unMET Indian need.Org: Rajiv Gandhi Cancer Institute and Research Center, Tata Memorial Hospital, Tata Memorial Centre,
Abstract
Patient’s perception of cancer treatment outcomes in geriatric age groups: A retrospective analysis from a tertiary care centre in India.Org: Tata Memorial Hospital, Tata Memorial Centre,
Clinical trial
Randomized Controlled Trial to Assess Blockade of Voltage Gated Sodium Channels During Surgery in Operable Breast CancerStatus: Active (not recruiting), Estimated PCD: 2026-10-31
Clinical trial
Phase I Study of Safety and Feasibility of Ayurvedic Oral Cannabis Preparation in the Peri-operative Period in Breast and Oral Cavity Squamous Cell CancerStatus: Active (not recruiting), Estimated PCD: 2024-12-31
Clinical trial
A Phase III Randomized Clinical Trial to Study the Radiosensitizing Effect of Nelfinavir in Locally Advanced Carcinoma of Uterine Cervix.Status: Recruiting, Estimated PCD: 2025-09-30
Clinical trial
A Phase II Randomized Controlled Trial of TKI Alone Versus TKI and Local Consolidative Radiation Therapy in Oncogene Driver Mutated Oligo Metastatic Non Small Cell Lung Cancer PatientsStatus: Recruiting, Estimated PCD: 2023-11-11
Clinical trial
Observation or Upfront Cranial RT in Oncogene Driver Mutated NSCLC With Asymptomatic Brain Metastases: A Phase III Randomized Controlled TrialStatus: Recruiting, Estimated PCD: 2024-07-01
Clinical trial
Standard Maintenance Therapy Versus Local Consolidative Radiation Therapy and Standard Maintenance Therapy in 1-5 Sites of Oligometastatic Non-small Cell Lung Cancer (NSCLC): A Phase III Randomized Controlled TrialStatus: Recruiting, Estimated PCD: 2026-04-20